Celularity Inc (CELU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,599 | -28,501 | -22,013 | -196,295 | -205,842 |
| Depreciation Amortization | 6,046 | 4,152 | 2,156 | 121,671 | 119,375 |
| Accounts receivable | 1,054 | -3,732 | -3,924 | -6,827 | -118 |
| Other Working Capital | 12,451 | 1,919 | -2,111 | 3,252 | 34,141 |
| Other Operating Activity | 17,053 | 18,311 | 21,489 | 39,514 | 18,100 |
| Operating Cash Flow | $-7,995 | $-7,851 | $-4,403 | $-38,685 | $-34,344 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -70 | -70 | -39 | -1,048 | -468 |
| Other Investing Activity | 2,175 | 2,175 | 0 | -3,000 | -3,000 |
| Investing Cash Flow | $2,105 | $2,105 | $-39 | $-4,048 | $-3,468 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 17,993 | 17,993 | 17,993 | 20,369 | 20,369 |
| Debt Issued | 6,000 | 6,000 | 6,000 | 12,750 | 12,750 |
| Common Stock Issued | N/A | N/A | N/A | 440 | 440 |
| Other Financing Activity | -17,935 | -17,856 | -17,766 | -9,465 | -9,451 |
| Financing Cash Flow | $6,058 | $6,137 | $6,227 | $24,094 | $24,108 |
| Beginning Cash Position | 10,163 | 10,163 | 10,163 | 28,802 | 28,802 |
| End Cash Position | 10,331 | 10,554 | 11,948 | 10,163 | 15,098 |
| Net Cash Flow | $168 | $391 | $1,785 | $-18,639 | $-13,704 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,995 | -7,851 | -4,403 | -38,685 | -34,344 |
| Capital Expenditure | -70 | -70 | -39 | -1,048 | -468 |
| Free Cash Flow | -8,065 | -7,921 | -4,442 | -39,733 | -34,812 |